DIA: Driving Insights to Action
Science:Life Sciences
CRISPR Therapeutics CEO Dr. Samarth Kulkarni spoke in the DIA 2018 Global Annual Meeting panel discussion session titled “Precision Medicine, Gene Editing, and Gene Therapy: Current Status and Regulatory Challenges of Integrating Genetic Medicine into Clinical Care.” He spoke after this session about the challenges of developing therapeutics involving gene therapy and gene editing with Session Chair Tshaka Cunningham, DIA Associate Director for Scientific Collaboration. Watch the video of this podcast interview.
More Episodes
DIA/Tufts CSDD Research: AI Saving Time in Drug Development
2025-01-17
482
2025-01-17
482
DIA: Your Partner in Life Sciences Training and Development
2024-11-06
320
2024-11-06
320
GPP Experts Explain Authorship Algorithm
2024-04-23
280
2024-04-23
280
"Dossier in the Cloud" Democratizing Global Access
2024-04-02
319
2024-04-02
319
DIA: A Place Where You Can Make a Difference
2024-03-28
262
2024-03-28
262
Retiring TGA Head Maps Australia’s Post-Pandemic Future
2023-07-17
398
2023-07-17
398
Patient Engagement: Evolution of Who Knows What, Part 2
2023-06-14
292
2023-06-14
292
Patient Engagement: Evolution of Who Knows What, Part 1
2023-06-12
433
2023-06-12
433
Rwanda Welcomes African Medicines Agency Home
2022-11-30
604
2022-11-30
604
Will Technology Solve the Research “People Problem”?
2022-11-22
377
2022-11-22
377
Why Trans/Nonbinary Research Benefits All Communities
2022-11-18
606
2022-11-18
606
Digital Revolutionizing Data-Driven Reimbursement
2022-10-20
403
2022-10-20
403
China Sets New Record for Local Drug Approvals in 2021
2022-09-15
437
2022-09-15
437
WHO Pilot Formalizes CSA Process to Assist Developers
2022-08-02
430
2022-08-02
430
Get this podcast on your
phone, FREE
